Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy Meeting Abstract
| Authors: | Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D. |
| Abstract Title: | Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy |
| Meeting Title: | 38th Annual Meeting of the American Society of Hematology |
| Journal Title: | Blood |
| Volume: | 88 |
| Issue: | 10 Suppl. 1 Pt. 1 |
| Meeting Dates: | 1996 Dec 6-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 1996-11-15 |
| Start Page: | 481a |
| Language: | English |
| ACCESSION: | WOS:A1996VT98301911 |
| PROVIDER: | wos |
| PUBMED: | 8939071 |
| Notes: | Meeting Abstract: 1911 -- Source: Wos |
Citation Impact
Related MSK Work